ValiantLtd Past Earnings Performance
Past criteria checks 2/6
ValiantLtd has been growing earnings at an average annual rate of 5.6%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 10% per year. ValiantLtd's return on equity is 8.1%, and it has net margins of 12.4%.
Key information
5.6%
Earnings growth rate
5.4%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 10.0% |
| Return on equity | 8.1% |
| Net Margin | 12.4% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How ValiantLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 3,892 | 484 | 491 | 410 |
| 30 Jun 24 | 4,188 | 589 | 515 | 418 |
| 31 Mar 24 | 4,210 | 685 | 512 | 398 |
| 31 Dec 23 | 4,305 | 763 | 494 | 365 |
| 30 Sep 23 | 4,412 | 653 | 572 | 353 |
| 30 Jun 23 | 4,567 | 620 | 597 | 328 |
| 31 Mar 23 | 4,742 | 665 | 594 | 339 |
| 01 Jan 23 | 5,080 | 721 | 578 | 358 |
| 30 Sep 22 | 4,977 | 778 | 504 | 351 |
| 30 Jun 22 | 5,135 | 816 | 459 | 376 |
| 31 Mar 22 | 4,943 | 728 | 448 | 338 |
| 01 Jan 22 | 4,359 | 627 | 437 | 295 |
| 30 Sep 21 | 4,193 | 649 | 402 | 313 |
| 30 Jun 21 | 3,481 | 589 | 372 | 259 |
| 31 Mar 21 | 3,036 | 512 | 351 | 240 |
| 31 Dec 20 | 2,918 | 505 | 341 | 250 |
| 30 Sep 20 | 2,877 | 489 | 347 | 224 |
| 30 Jun 20 | 2,824 | 492 | 350 | 214 |
| 31 Mar 20 | 2,877 | 530 | 358 | 232 |
| 31 Dec 19 | 2,870 | 507 | 362 | 219 |
| 30 Sep 19 | 2,725 | 505 | 372 | 216 |
| 30 Jun 19 | 2,647 | 482 | 369 | 211 |
| 31 Mar 19 | 2,636 | 482 | 379 | 183 |
| 31 Dec 18 | 2,632 | 444 | 373 | 194 |
| 30 Sep 18 | 2,509 | 389 | 358 | 161 |
| 30 Jun 18 | 2,472 | 364 | 289 | 223 |
| 31 Mar 18 | 2,502 | 350 | 311 | 185 |
| 31 Dec 17 | 2,456 | 385 | 347 | 136 |
| 30 Sep 17 | 2,320 | 370 | 363 | 98 |
| 30 Jun 17 | 2,221 | 347 | 454 | 0 |
| 31 Mar 17 | 2,037 | 328 | 431 | 0 |
| 31 Dec 16 | 1,847 | 319 | 378 | 0 |
| 30 Sep 16 | 1,933 | 363 | 339 | 0 |
| 30 Jun 16 | 1,904 | 373 | 309 | 0 |
| 31 Mar 16 | 1,788 | 324 | 279 | 0 |
| 31 Dec 15 | 1,631 | 258 | 283 | 0 |
| 30 Sep 15 | 1,386 | 179 | 256 | 0 |
| 30 Jun 15 | 1,251 | 130 | 235 | 0 |
| 31 Mar 15 | 1,138 | 103 | 203 | 0 |
| 31 Dec 14 | 1,069 | 97 | 181 | 0 |
| 30 Sep 14 | 965 | 97 | 163 | 0 |
| 30 Jun 14 | 915 | 98 | 150 | 0 |
| 31 Mar 14 | 941 | 110 | 144 | 0 |
| 31 Dec 13 | 965 | 124 | 135 | 0 |
Quality Earnings: 002643 has high quality earnings.
Growing Profit Margin: 002643's current net profit margins (12.4%) are lower than last year (14.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 002643's earnings have grown by 5.6% per year over the past 5 years.
Accelerating Growth: 002643's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 002643 had negative earnings growth (-26%) over the past year, making it difficult to compare to the Chemicals industry average (-5.3%).
Return on Equity
High ROE: 002643's Return on Equity (8.1%) is considered low.